[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Pramipexole.]
[J01GA01, streptomycin, Pramipexole may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, Succinylcholine may increase the sedative activities of Pramipexole.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01CG01, sulbactam, Pramipexole may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Pramipexole may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AL01, sulpiride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Sulpiride.]
[N03AX03, sulthiame, Sulthiame may increase the sedative activities of Pramipexole.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CD07, temazepam, Temazepam may increase the sedative activities of Pramipexole.]
[R03CC03, terbutaline, Pramipexole may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Pramipexole may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Pramipexole may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, Tetracaine may increase the sedative activities of Pramipexole.]
[S03AA02, tetracycline, Pramipexole may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AE05, lurasidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the sedative activities of Pramipexole.]
[N04BC07, apomorphine, Apomorphine may increase the sedative activities of Pramipexole.]
[L04AX02, thalidomide, Thalidomide may increase the sedative activities of Pramipexole.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Pramipexole may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[A11DA01, thiamine, The serum concentration of Pramipexole can be increased when it is combined with Thiamine.]
[R06AD03, thiethylperazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Thiethylperazine.]
[N05CA19, thiopental, Thiopental may increase the sedative activities of Pramipexole.]
[N05AB08, thioproperazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Thioproperazine.]
[N05AC02, thioridazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Thioridazine.]
[N05AF04, thiothixene, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Thiothixene.]
[G04BE06, moxisylyte, Pramipexole may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Tiapride.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02AX01, tilidine, Tilidine may increase the sedative activities of Pramipexole.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Pramipexole.]
[P01AB02, tinidazole, Pramipexole may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Pramipexole may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Pramipexole may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Pramipexole is combined with Tolazoline.]
[V04CA01, tolbutamide, Pramipexole may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M03BX04, tolperisone, Tolperisone may increase the sedative activities of Pramipexole.]
[N02AX02, tramadol, Tramadol may increase the sedative activities of Pramipexole.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the sedative activities of Pramipexole.]
[N06AX05, trazodone, Trazodone may increase the sedative activities of Pramipexole.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Tretinoin.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may increase the sedative activities of Pramipexole.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Pramipexole may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Trifluoperazine.]
[S01AD02, trifluridine, Pramipexole may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[N05AD02, trifluperidol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Trifluperidol.]
[N05AA05, triflupromazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Triflupromazine.]
[A03AA05, trimebutine, Pramipexole may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[R06AD01, trimeprazine, Alimemazine may increase the sedative activities of Pramipexole.]
[N03AC02, trimethadione, Trimethadione may increase the sedative activities of Pramipexole.]
[C02BA01, trimethaphan, Pramipexole may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The serum concentration of Pramipexole can be increased when it is combined with Trimethoprim.]
[N06AA06, trimipramine, Trimipramine may increase the sedative activities of Pramipexole.]
[R06AX07, triprolidine, Triprolidine may increase the sedative activities of Pramipexole.]
[N06AX24, vilazodone, Vilazodone may increase the sedative activities of Pramipexole.]
[N06AX02, tryptophan, Tryptophan may increase the sedative activities of Pramipexole.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Pramipexole is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, Tubocurarine may increase the sedative activities of Pramipexole.]
[R03DX07, roflumilast, Pramipexole may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Pramipexole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The serum concentration of Pramipexole can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Pramipexole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Pramipexole can be increased when it is combined with Linagliptin.]
[S01AA28, vancomycin, Pramipexole may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may increase the sedative activities of Pramipexole.]
[B01AF01, rivaroxaban, Pramipexole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Verapamil is combined with Pramipexole.]
[N06AX09, viloxazine, Viloxazine may increase the sedative activities of Pramipexole.]
[C04AX07, vincamine, Pramipexole may increase the hypotensive activities of Vincamine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[B01AA03, warfarin, Pramipexole may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Zuclopenthixol.]
[J05AE02, indinavir, The risk or severity of adverse effects can be increased when Indinavir is combined with Pramipexole.]
[N03AX14, levetiracetam, Levetiracetam may increase the sedative activities of Pramipexole.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M05BA05, tiludronic acid, Pramipexole may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Pramipexole may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Pramipexole can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Pramipexole may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N05AE04, ziprasidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Pramipexole may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Pramipexole may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Pramipexole may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Pramipexole may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Pramipexole.]
[M03AC04, atracurium, Atracurium may increase the sedative activities of Pramipexole.]
[M01CB03, auranofin, Pramipexole may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Pramipexole may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Pramipexole may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Pramipexole may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Pramipexole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G04BE10, avanafil, The risk or severity of hypotension can be increased when Avanafil is combined with Pramipexole.]
[M03BX01, baclofen, Baclofen may increase the sedative activities of Pramipexole.]
[A08AA11, lorcaserin, Lorcaserin may increase the sedative activities of Pramipexole.]
[G04BD12, mirabegron, Pramipexole may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Pramipexole may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[N05CA04, barbital, Barbital may increase the sedative activities of Pramipexole.]
[D02BA02, octinoxate, Pramipexole may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The risk or severity of adverse effects can be increased when Nelfinavir is combined with Pramipexole.]
[N04BD02, rasagiline, Rasagiline may increase the sedative activities of Pramipexole.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Lercanidipine.]
[A03FA09, mosapride, Mosapride may increase the sedative activities of Pramipexole.]
[N06DA02, donepezil, Donepezil may increase the sedative activities of Pramipexole.]
[N03AX22, perampanel, Perampanel may increase the sedative activities of Pramipexole.]
[N02CC03, zolmitriptan, Zolmitriptan may increase the sedative activities of Pramipexole.]
[V09IX04, fluorodeoxyglucose F18, Pramipexole may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may increase the sedative activities of Pramipexole.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Sildenafil is combined with Pramipexole.]
[V08CA11, gadofosveset, Pramipexole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Pramipexole may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Pramipexole may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Pramipexole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Pomalidomide may increase the sedative activities of Pramipexole.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AD07, benperidol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Benperidol.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, Benzocaine may increase the sedative activities of Pramipexole.]
[L03AA12, ancestim, Pramipexole may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02CC02, naratriptan, Naratriptan may increase the sedative activities of Pramipexole.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Pramipexole can be increased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01EE01, trametinib, Pramipexole may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, Benzyl alcohol may increase the sedative activities of Pramipexole.]
[V09AX05, florbetapir F-18, Pramipexole may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the sedative activities of Pramipexole.]
[J05AJ03, dolutegravir, The serum concentration of Pramipexole can be increased when it is combined with Dolutegravir.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Pramipexole is combined with Bepridil.]
[C02KX05, riociguat, The risk or severity of adverse effects can be increased when Pramipexole is combined with Riociguat.]
[A10BJ03, lixisenatide, Pramipexole may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Pramipexole may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Vortioxetine may increase the sedative activities of Pramipexole.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the sedative activities of Pramipexole.]
[J05AP08, sofosbuvir, Pramipexole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, Vigabatrin may increase the sedative activities of Pramipexole.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Pramipexole may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Acebutolol.]
[N05CH03, tasimelteon, Tasimelteon may increase the sedative activities of Pramipexole.]
[L04AA32, apremilast, Pramipexole may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Pramipexole may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Pramipexole.]
[V03AB34, fomepizole, Pramipexole may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, Pramipexole may increase the hypotensive activities of Bethanidine.]
[N01AX05, alfaxalone, Alfaxalone may increase the sedative activities of Pramipexole.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Empagliflozin.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CM19, suvorexant, Suvorexant may increase the sedative activities of Pramipexole.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AA04, acepromazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Acepromazine.]
[S03AA06, gentamicin, Pramipexole may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Pramipexole may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Mirtazapine may increase the sedative activities of Pramipexole.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Pramipexole.]
[L01EX08, lenvatinib, The serum concentration of Pramipexole can be increased when it is combined with Lenvatinib.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AX16, brexpiprazole, Brexpiprazole may increase the sedative activities of Pramipexole.]
[G02CX02, flibanserin, Flibanserin may increase the sedative activities of Pramipexole.]
[N05AX15, cariprazine, Cariprazine may increase the sedative activities of Pramipexole.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the sedative activities of Pramipexole.]
[N05AB07, acetophenazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Acetophenazine.]
[V03AB37, idarucizumab, Pramipexole may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J02AC05, isavuconazole, The serum concentration of Pramipexole can be increased when it is combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Pramipexole.]
[L01XG03, ixazomib, Pramipexole may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, Pramipexole may increase the hypotensive activities of Selexipag.]
[M04AB05, lesinurad, Pramipexole may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[A03FA05, alizapride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Alizapride.]
[N05CA05, aprobarbital, Aprobarbital may increase the sedative activities of Pramipexole.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may increase the sedative activities of Pramipexole.]
[N05BA08, bromazepam, Bromazepam may increase the sedative activities of Pramipexole.]
[N04BC01, bromocriptine, Bromocriptine may increase the sedative activities of Pramipexole.]
[A02AD05, aluminum magnesium silicate, Pramipexole may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A03AX08, alverine, Alverine may increase the sedative activities of Pramipexole.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the sedative activities of Pramipexole.]
[N06AA19, amineptin, Amineptine may increase the sedative activities of Pramipexole.]
[C08CA01, amlodipine, The risk or severity of adverse effects can be increased when Amlodipine is combined with Pramipexole.]
[N06BX11, aniracetam, Aniracetam may increase the sedative activities of Pramipexole.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Bupivacaine may increase the sedative activities of Pramipexole.]
[C07AA19, bupranolol, Pramipexole may increase the hypotensive activities of Bupranolol.]
[N07BC01, buprenorphine, Buprenorphine may increase the sedative activities of Pramipexole.]
[N05BE01, buspirone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Buspirone.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Pramipexole is combined with Arsenic trioxide.]
[M02AA03, clofezone, Pramipexole may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N02AF01, butorphanol, Butorphanol may increase the sedative activities of Pramipexole.]
[S01GX07, azelastine, Azelastine may increase the sedative activities of Pramipexole.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A06AH05, naldemedine, Pramipexole may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Pramipexole may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may increase the sedative activities of Pramipexole.]
[N03AX30, beclamide, Beclamide may increase the sedative activities of Pramipexole.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Benazepril.]
[S01HA02, benoxinate, Oxybuprocaine may increase the sedative activities of Pramipexole.]
[P01CA02, benznidazole, Pramipexole may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Pramipexole.]
[J05AF06, abacavir, Pramipexole may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Pramipexole may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the sedative activities of Pramipexole.]
[J01MA23, delafloxacin, Pramipexole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Pramipexole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The serum concentration of Pramipexole can be increased when it is combined with Enasidenib.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Bisoprolol.]
[J05AG03, efavirenz, Efavirenz may increase the sedative activities of Pramipexole.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nesiritide.]
[A03FA04, bromopride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Bromopride.]
[N05AD06, bromperidol, Bromperidol may increase the sedative activities of Pramipexole.]
[N05CD09, brotizolam, Brotizolam may increase the sedative activities of Pramipexole.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Pramipexole may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CA03, butobarbital, Butobarbital may increase the sedative activities of Pramipexole.]
[N06AA15, butriptyline, Butriptyline may increase the sedative activities of Pramipexole.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA08, butylvinal, Vinylbital may increase the sedative activities of Pramipexole.]
[R06AX18, acrivastine, Pramipexole may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Captopril.]
[L02BB05, apalutamide, The serum concentration of Pramipexole can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, Carbamazepine may increase the sedative activities of Pramipexole.]
[R06AA08, carbinoxamine, Carbinoxamine may increase the sedative activities of Pramipexole.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Pramipexole.]
[N03AX24, cannabidiol, Cannabidiol may increase the sedative activities of Pramipexole.]
[L04AA37, baricitinib, Pramipexole may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01GB14, plazomicin, Pramipexole may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Pramipexole may increase the hypotensive activities of Celiprolol.]
[P01BA07, tafenoquine, The serum concentration of Pramipexole can be increased when it is combined with Tafenoquine.]
[A16AX14, migalastat, Pramipexole may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Stiripentol may increase the sedative activities of Pramipexole.]
[L01EB07, dacomitinib, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Pramipexole.]
[S01GX12, cetirizine, Cetirizine may increase the sedative activities of Pramipexole.]
[N05CM04, carbromal, Carbromal may increase the sedative activities of Pramipexole.]
[N01BA04, chloroprocaine, Chloroprocaine may increase the sedative activities of Pramipexole.]
[D08AE05, chloroxylenol, Pramipexole may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M03BA02, carisoprodol, Carisoprodol may increase the sedative activities of Pramipexole.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01EX13, gilteritinib, The risk or severity of adverse effects can be increased when Gilteritinib is combined with Pramipexole.]
[A06AX05, prucalopride, Pramipexole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Cilazapril.]
[B01AC23, cilostazol, Pramipexole may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may increase the sedative activities of Pramipexole.]
[N06AX27, esketamine, Esketamine may increase the sedative activities of Pramipexole.]
[N06BA14, solriamfetol, Solriamfetol may increase the sedative activities of Pramipexole.]
[N06AX29, brexanolone, Brexanolone may increase the sedative activities of Pramipexole.]
[A03FA06, clebopride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Clebopride.]
[L01EN01, erdafitinib, The serum concentration of Pramipexole can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, Clobazam may increase the sedative activities of Pramipexole.]
[N05BA22, cloxazolam, Cloxazolam may increase the sedative activities of Pramipexole.]
[C09CA06, candesartan, Pramipexole may increase the hypotensive activities of Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AA06, cyamemazine, Cyamemazine may increase the sedative activities of Pramipexole.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the sedative activities of Pramipexole.]
[N07XX11, pitolisant, The risk or severity of adverse effects can be increased when Pitolisant is combined with Pramipexole.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Yohimbine.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02CC08, lasmiditan, Lasmiditan may increase the sedative activities of Pramipexole.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M09AX08, golodirsen, Pramipexole may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the sedative activities of Pramipexole.]
[S01XA12, dexpanthenol, Pramipexole may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, Dezocine may increase the sedative activities of Pramipexole.]
[N05CM21, lemborexant, Lemborexant may increase the sedative activities of Pramipexole.]
[N05AD10, lumateperone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Lumateperone.]
[N02CC07, frovatriptan, Frovatriptan may increase the sedative activities of Pramipexole.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the sedative activities of Pramipexole.]
[R02AA03, dichlorobenzyl alcohol, Pramipexole may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Pramipexole may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[A07DA04, difenoxin, Difenoxin may increase the sedative activities of Pramipexole.]
[N02AA08, dihydrocodeine, Dihydrocodeine may increase the sedative activities of Pramipexole.]
[N02CC06, eletriptan, Eletriptan may increase the sedative activities of Pramipexole.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Pramipexole can be increased when it is combined with Dronedarone.]
[N03AG02, dipropylacetamide, Valpromide may increase the sedative activities of Pramipexole.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the sedative activities of Pramipexole.]
[C02AA06, methoserpidine, Pramipexole may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The serum concentration of Pramipexole can be increased when it is combined with Tucatinib.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Pramipexole is combined with Opicapone.]
[C01CA14, dopexamine, The risk or severity of adverse effects can be decreased when Pramipexole is combined with Dopexamine.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V08CA05, mangafodipir, Pramipexole may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CM02, chlormethiazole, Clomethiazole may increase the sedative activities of Pramipexole.]
[M03BB02, chlormezanone, Chlormezanone may increase the sedative activities of Pramipexole.]
[R02AD04, dyclonine, Dyclonine may increase the sedative activities of Pramipexole.]
[C08CA17, levamlodipine, Pramipexole may increase the hypotensive activities of Levamlodipine.]
[N05CD14, remimazolam, Remimazolam may increase the sedative activities of Pramipexole.]
[N02AX07, oliceridine, Oliceridine may increase the sedative activities of Pramipexole.]
[P01BA01, chloroquine, Pramipexole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, Chlorpheniramine may increase the sedative activities of Pramipexole.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Chlorpromazine.]
[A10BB02, chlorpropamide, Pramipexole may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Chlorprothixene.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may increase the sedative activities of Pramipexole.]
[N05BX03, etifoxine, Etifoxine may increase the sedative activities of Pramipexole.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02BA03, choline salicylate, The serum concentration of Pramipexole can be increased when it is combined with Choline salicylate.]
[N06BX18, vinpocetine, Vinpocetine may increase the sedative activities of Pramipexole.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the sedative activities of Pramipexole.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M01AX25, chondroitin sulfates, Pramipexole may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Pramipexole is combined with Vericiguat.]
[V03AF12, trilaciclib, The serum concentration of Pramipexole can be increased when it is combined with Trilaciclib.]
[M03BA05, febarbamate, Febarbamate may increase the sedative activities of Pramipexole.]
[N03AX10, felbamate, Felbamate may increase the sedative activities of Pramipexole.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be decreased when Pramipexole is combined with Fenoldopam.]
[J01DD15, cefdinir, Pramipexole may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Pramipexole may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Pramipexole may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Formoterol is combined with Pramipexole.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the sedative activities of Pramipexole.]
[H04AA02, dasiglucagon, Pramipexole may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The serum concentration of Pramipexole can be increased when it is combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the sedative activities of Pramipexole.]
[V08CA04, gadoteridol, Pramipexole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[S03AA07, ciprofloxacin, Pramipexole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, Pramipexole may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, Citalopram may increase the sedative activities of Pramipexole.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The serum concentration of Pramipexole can be increased when it is combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Pramipexole may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Pramipexole may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Pramipexole may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, Clemastine may increase the sedative activities of Pramipexole.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AX25, St. John's wort extract, St. John's Wort may increase the sedative activities of Pramipexole.]
[N01BB10, levobupivacaine, Levobupivacaine may increase the sedative activities of Pramipexole.]
[L01EJ03, pacritinib, The serum concentration of Pramipexole can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Clomipramine may increase the sedative activities of Pramipexole.]
[N03AE01, clonazepam, Clonazepam may increase the sedative activities of Pramipexole.]
[S01EA04, clonidine, Clonidine may increase the sedative activities of Pramipexole.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH06, clothiapine, Clothiapine may increase the sedative activities of Pramipexole.]
[N05BA21, clotiazepam, Clotiazepam may increase the sedative activities of Pramipexole.]
[A04AA01, ondansetron, Ondansetron may increase the sedative activities of Pramipexole.]
[A04AA02, granisetron, Granisetron may increase the sedative activities of Pramipexole.]
[N05AH02, clozapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Clozapine.]
[J01GB12, arbekacin, Pramipexole may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[N05BA13, halazepam, Halazepam may increase the sedative activities of Pramipexole.]
[C02KB01, metyrosine, Pramipexole may increase the hypotensive activities of Metyrosine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R05DA04, codeine, Codeine may increase the sedative activities of Pramipexole.]
[M03AC05, hexafluorenium, Hexafluronium may increase the sedative activities of Pramipexole.]
[M04AC01, colchicine, Pramipexole may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Pramipexole may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may increase the sedative activities of Pramipexole.]
[A04AA03, tropisetron, Tropisetron may increase the sedative activities of Pramipexole.]
[C04AX28, ifenprodil, Ifenprodil may increase the sedative activities of Pramipexole.]
[A10BX03, nateglinide, Pramipexole may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R06AX27, desloratadine, Desloratadine may increase the sedative activities of Pramipexole.]
[J05AB14, valganciclovir, Pramipexole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Pramipexole may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Pramipexole may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Pramipexole may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Pramipexole may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Pramipexole may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may increase the sedative activities of Pramipexole.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Acyclovir is combined with Pramipexole.]
[N05BA10, ketazolam, Ketazolam may increase the sedative activities of Pramipexole.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Pramipexole can be increased when it is combined with Imatinib.]
[C08CA09, lacidipine, Pramipexole may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may increase the sedative activities of Pramipexole.]
[S01GX02, levocabastine, Levocabastine may increase the sedative activities of Pramipexole.]
[N07BC04, lofexidine, Lofexidine may increase the sedative activities of Pramipexole.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CD06, lormetazepam, Lormetazepam may increase the sedative activities of Pramipexole.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Pramipexole may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, Pramipexole may increase the hypotensive activities of Manidipine.]
[N06AX13, medifoxamine, Medifoxamine may increase the sedative activities of Pramipexole.]
[J01DH02, meropenem, Pramipexole may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[R06AE03, cyclizine, Cyclizine may increase the sedative activities of Pramipexole.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the sedative activities of Pramipexole.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AX07, minaprine, Minaprine may increase the sedative activities of Pramipexole.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AG02, moclobemide, Moclobemide may increase the sedative activities of Pramipexole.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the sedative activities of Pramipexole.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Moexipril.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Moxonidine.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Pramipexole.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01AX04, dacarbazine, Pramipexole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03CA01, dantrolene, Dantrolene may increase the sedative activities of Pramipexole.]
[N06BX04, deanol, Deanol may increase the sedative activities of Pramipexole.]
[C02CC04, debrisoquin, Pramipexole may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the sedative activities of Pramipexole.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N07BB05, nalmefene, Pramipexole may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[N05BA16, nordazepam, Nordazepam may increase the sedative activities of Pramipexole.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nebivolol.]
[S01GX04, nedocromil, Pramipexole may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may increase the sedative activities of Pramipexole.]
[N05CM16, niaprazine, Niaprazine may increase the sedative activities of Pramipexole.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Pramipexole.]
[L02BB02, nilutamide, Pramipexole may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[N03AG06, tiagabine, Tiagabine may increase the sedative activities of Pramipexole.]
[M03AC11, cisatracurium, Cisatracurium may increase the sedative activities of Pramipexole.]
[R05DA06, normethadone, Normethadone may increase the sedative activities of Pramipexole.]
[B01AX05, fondaparinux, Pramipexole may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[N06AB10, escitalopram, Escitalopram may increase the sedative activities of Pramipexole.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AA01, desipramine, Desipramine may increase the sedative activities of Pramipexole.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V04CH02, indigo carmine, Pramipexole may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Pramipexole is combined with Aliskiren.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the sedative activities of Pramipexole.]
[N06BX07, oxiracetam, Oxiracetam may increase the sedative activities of Pramipexole.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R05DA09, dextromethorphan, Dextromethorphan may increase the sedative activities of Pramipexole.]
[N03AC01, paramethadione, Paramethadione may increase the sedative activities of Pramipexole.]
[N02AC01, dextromoramide, Dextromoramide may increase the sedative activities of Pramipexole.]
[N06AB05, paroxetine, Paroxetine may increase the sedative activities of Pramipexole.]
[B01AC04, clopidogrel, The serum concentration of Pramipexole can be increased when it is combined with Clopidogrel.]
[N07BC06, heroin, Diamorphine may increase the sedative activities of Pramipexole.]
[P03AC04, permethrin, Pramipexole may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may increase the sedative activities of Pramipexole.]
[N03AX07, phenacemide, Phenacemide may increase the sedative activities of Pramipexole.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Pramipexole is combined with Diazoxide.]
[N03AD02, phensuximide, Phensuximide may increase the sedative activities of Pramipexole.]
[N06AA08, dibenzepin, Dibenzepin may increase the sedative activities of Pramipexole.]
[S02DA04, dibucaine, Cinchocaine may increase the sedative activities of Pramipexole.]
[R05DA08, pholcodine, Pramipexole may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A03AA07, dicyclomine, Pramipexole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Pramipexole may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, Pramipexole may increase the hypotensive activities of Pinacidil.]
[N05AD05, pipamperone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Pipamperone.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Diethylpropion may increase the sedative activities of Pramipexole.]
[C08CA03, isradipine, The risk or severity of adverse effects can be increased when Isradipine is combined with Pramipexole.]
[D07XC04, diflucortolone, Pramipexole may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01AA05, digoxin, Pramipexole may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, Pramipexole may increase the hypotensive activities of Dihydralazine.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the sedative activities of Pramipexole.]
[N02AA03, hydromorphone, Hydromorphone may increase the sedative activities of Pramipexole.]
[L04AX04, lenalidomide, Pramipexole may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[B01AC21, treprostinil, Pramipexole may increase the hypotensive activities of Treprostinil.]
[H03BC01, potassium perchlorate, Pramipexole may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pramipexole may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, Pramocaine may increase the sedative activities of Pramipexole.]
[C08DB01, diltiazem, The risk or severity of adverse effects can be increased when Diltiazem is combined with Pramipexole.]
[R06AA11, dimenhydrinate, Dimenhydrinate may increase the sedative activities of Pramipexole.]
[V03AB09, dimercaprol, Pramipexole may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M03BX03, pridinol, Pridinol may increase the sedative activities of Pramipexole.]
[M02AX03, dimethyl sulfoxide, Pramipexole may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N03AG05, progabide, Progabide may increase the sedative activities of Pramipexole.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G02AD02, dinoprostone, The serum concentration of Pramipexole can be increased when it is combined with Dinoprostone.]
[R06AA02, diphenhydramine, Diphenhydramine may increase the sedative activities of Pramipexole.]
[A07DA01, diphenoxylate, Diphenoxylate may increase the sedative activities of Pramipexole.]
[N05CD10, quazepam, Quazepam may increase the sedative activities of Pramipexole.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Pramipexole is combined with Dipyridamole.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the sedative activities of Pramipexole.]
[N06AA23, quinupramine, Quinupramine may increase the sedative activities of Pramipexole.]
[A03FA02, cisapride, Cisapride may increase the sedative activities of Pramipexole.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Pramipexole.]
[N05AL04, remoxipride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Remoxipride.]
[S01AX06, resorcinol, Pramipexole may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The serum concentration of Pramipexole can be increased when it is combined with Disopyramide.]
[N07XX02, riluzole, Riluzole may increase the sedative activities of Pramipexole.]
[N05AX08, risperidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Risperidone.]
[R06AE09, levocetirizine, Levocetirizine may increase the sedative activities of Pramipexole.]
[N01BB09, ropivacaine, Ropivacaine may increase the sedative activities of Pramipexole.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Pramipexole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02KX02, ambrisentan, Pramipexole may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Pramipexole can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R03AC12, salmeterol, The serum concentration of Pramipexole can be increased when it is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01CA07, dobutamine, Pramipexole may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[A03FA03, domperidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Domperidone.]
[C01CA04, dopamine, The serum concentration of Pramipexole can be increased when it is combined with Dopamine.]
[N06AA16, dothiepin, Dosulepin may increase the sedative activities of Pramipexole.]
[N06AA12, doxepin, Doxepin may increase the sedative activities of Pramipexole.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the sedative activities of Pramipexole.]
[N06AB06, sertraline, Sertraline may increase the sedative activities of Pramipexole.]
[N01AB08, sevoflurane, Sevoflurane may increase the sedative activities of Pramipexole.]
[N05AD08, droperidol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Droperidol.]
[A08AA10, sibutramine, Sibutramine may increase the sedative activities of Pramipexole.]
[A12CA02, sodium sulfate, Pramipexole may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, Pramipexole may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, Pramipexole may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N05AL02, sultopride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Sultopride.]
[N02CC01, sumatriptan, Sumatriptan may increase the sedative activities of Pramipexole.]
[V04CX07, edrophonium, Pramipexole may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, Pramipexole may increase the hypotensive activities of Talinolol.]
[L01AX03, temozolomide, Pramipexole may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Terazosin.]
[M03BX07, tetrazepam, Tetrazepam may increase the sedative activities of Pramipexole.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the sedative activities of Pramipexole.]
[N05AB05, thiopropazate, Thiopropazate may increase the sedative activities of Pramipexole.]
[G04BD01, emepronium, Emepronium may increase the sedative activities of Pramipexole.]
[N06AX14, tianeptine, Tianeptine may increase the sedative activities of Pramipexole.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Enalapril.]
[N05BA23, tofisopam, Tofisopam may increase the sedative activities of Pramipexole.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may increase the sedative activities of Pramipexole.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may increase the sedative activities of Pramipexole.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Trandolapril.]
[N05CD11, triazulenone, Loprazolam may increase the sedative activities of Pramipexole.]
[N05CC01, chloral hydrate, Chloral hydrate may increase the sedative activities of Pramipexole.]
[N05CM07, triclofos, Triclofos may increase the sedative activities of Pramipexole.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the sedative activities of Pramipexole.]
[N01AB04, enflurane, Enflurane may increase the sedative activities of Pramipexole.]
[C02CA06, urapidil, Urapidil may increase the sedative activities of Pramipexole.]
[N05AL06, veralipride, Veralipride may increase the sedative activities of Pramipexole.]
[S01GX10, epinastine, Epinastine may increase the sedative activities of Pramipexole.]
[N06AX16, venlafaxine, Venlafaxine may increase the sedative activities of Pramipexole.]
[C08CA12, mepirodipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Barnidipine.]
[S01EA01, epinephrine, The serum concentration of Pramipexole can be increased when it is combined with Epinephrine.]
[C09AA15, zofenopril, Pramipexole may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, Zolpidem may increase the sedative activities of Pramipexole.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the sedative activities of Pramipexole.]
[N05CF01, zopiclone, Zopiclone may increase the sedative activities of Pramipexole.]
[N05AX11, zotepine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Zotepine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may increase the sedative activities of Pramipexole.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Pramipexole is combined with Iloprost.]
[C01BG01, moricizine, Moricizine may increase the sedative activities of Pramipexole.]
[G02AB03, ergonovine, Ergometrine may increase the sedative activities of Pramipexole.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the sedative activities of Pramipexole.]
[N02CA02, ergotamine, Ergotamine may increase the sedative activities of Pramipexole.]
[N03AG01, valproic acid, Valproic acid may increase the sedative activities of Pramipexole.]
[L03AX05, pidotimod, Pramipexole may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Estazolam may increase the sedative activities of Pramipexole.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G03CA03, estradiol, The serum concentration of Pramipexole can be increased when it is combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the sedative activities of Pramipexole.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AD01, ethosuximide, Ethosuximide may increase the sedative activities of Pramipexole.]
[N03AB01, ethotoin, Ethotoin may increase the sedative activities of Pramipexole.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01XA06, ethylmorphine, Ethylmorphine may increase the sedative activities of Pramipexole.]
[N01AX07, etomidate, Etomidate may increase the sedative activities of Pramipexole.]
[N05AE03, sertindole, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Sertindole.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[P01AX07, trimetrexate, Pramipexole may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The excretion of Pramipexole can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, Fluvoxamine may increase the sedative activities of Pramipexole.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Pramipexole may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Pramipexole may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A02BA03, famotidine, The serum concentration of Pramipexole can be increased when it is combined with Famotidine.]
[A16AA01, levocarnitine, Pramipexole may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[C08CA02, felodipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Felodipine.]
[N03AX26, fenfluramine, Fenfluramine may increase the sedative activities of Pramipexole.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may increase the sedative activities of Pramipexole.]
[R03CC02, albuterol, Pramipexole may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Clofarabine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G04BD02, flavoxate, Pramipexole may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J02AX01, flucytosine, Pramipexole may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Pramipexole may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Flunarizine may increase the sedative activities of Pramipexole.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the sedative activities of Pramipexole.]
[N06AA14, melitracen, Melitracen may increase the sedative activities of Pramipexole.]
[V03AZ01, ethanol, Ethanol may increase the sedative activities of Pramipexole.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AB03, fluoxetine, Fluoxetine may increase the sedative activities of Pramipexole.]
[N05AF01, flupenthixol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Flupentixol.]
[N05AB02, fluphenazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Fluphenazine.]
[N05CD01, flurazepam, Flurazepam may increase the sedative activities of Pramipexole.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AG01, fluspirilene, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Fluspirilene.]
[L02BB01, flutamide, Pramipexole may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S02AA17, fosfomycin, Pramipexole may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L01BC03, tegafur, Pramipexole may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[M03AA01, alcuronium, Alcuronium may increase the sedative activities of Pramipexole.]
[G01AX06, furazolidone, Furazolidone may increase the sedative activities of Pramipexole.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may increase the sedative activities of Pramipexole.]
[N05AL05, amisulpride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Amisulpride.]
[M03AC02, gallamine, Gallamine may increase the sedative activities of Pramipexole.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Pramipexole.]
[N03AA04, barbexaclone, Barbexaclone may increase the sedative activities of Pramipexole.]
[N06AX08, bifemelane, Bifemelane may increase the sedative activities of Pramipexole.]
[C10AB04, gemfibrozil, Pramipexole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Pramipexole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Cabergoline may increase the sedative activities of Pramipexole.]
[N03AD03, methsuximide, Methsuximide may increase the sedative activities of Pramipexole.]
[N01AH02, alfentanil, Alfentanil may increase the sedative activities of Pramipexole.]
[A10BB07, glipizide, Pramipexole may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may increase the sedative activities of Pramipexole.]
[N05CE01, glutethimide, Glutethimide may increase the sedative activities of Pramipexole.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitroglycerin.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Pramipexole.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Pramipexole.]
[M01CB04, aurothioglucose, Pramipexole may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pramipexole may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Fosinopril.]
[S01EX01, guanethidine, Pramipexole may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AD01, haloperidol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Haloperidol.]
[N01AB01, halothane, Halothane may increase the sedative activities of Pramipexole.]
[N05AH04, quetiapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Quetiapine.]
[N06BX13, idebenone, Pramipexole may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[N02CX03, iprazochrome, Iprazochrome may increase the sedative activities of Pramipexole.]
[N05CA21, allobarbital, Allobarbital may increase the sedative activities of Pramipexole.]
[M04AA01, allopurinol, Pramipexole may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Pramipexole is combined with Losartan.]
[G03DC01, allylestrenol, Pramipexole may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CA16, hexobarbital, Hexobarbital may increase the sedative activities of Pramipexole.]
[J05AG01, nevirapine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Pramipexole.]
[C08CA10, nilvadipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, Hydrocodone may increase the sedative activities of Pramipexole.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Pramipexole may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G04BD06, propiverine, Pramipexole may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[N05AX07, prothipendyl, Prothipendyl may increase the sedative activities of Pramipexole.]
[B05AA07, hetastarch, Pramipexole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the sedative activities of Pramipexole.]
[C02AC06, rilmenidine, Pramipexole may increase the hypotensive activities of Rilmenidine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[B05XA08, sodium acetate, Pramipexole may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Pramipexole may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, Sufentanil may increase the sedative activities of Pramipexole.]
[N06AA02, imipramine, Imipramine may increase the sedative activities of Pramipexole.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Pramipexole is combined with Paclitaxel.]
[R01AD07, tixocortol, Pramipexole may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, Tizanidine may increase the sedative activities of Pramipexole.]
[L01CE01, topotecan, Pramipexole may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Indoramin.]
[A11HA07, inositol, Pramipexole may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Milnacipran may increase the sedative activities of Pramipexole.]
[S01XA28, varenicline, The serum concentration of Pramipexole can be increased when it is combined with Varenicline.]
[N01BB08, articaine, Articaine may increase the sedative activities of Pramipexole.]
[A10BH01, sitagliptin, Pramipexole may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may increase the sedative activities of Pramipexole.]
[N05CH02, ramelteon, Ramelteon may increase the sedative activities of Pramipexole.]
[C07AA01, alprenolol, Alprenolol may increase the sedative activities of Pramipexole.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Pramipexole may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may increase the sedative activities of Pramipexole.]
[N06AF05, iproniazid, Iproniazid may increase the sedative activities of Pramipexole.]
[N05AA07, chlorproethazine, Chlorproethazine may increase the sedative activities of Pramipexole.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the sedative activities of Pramipexole.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Pramipexole is combined with Imidapril.]
[N01AB06, isoflurane, Isoflurane may increase the sedative activities of Pramipexole.]
[N04BX02, entacapone, Entacapone may increase the sedative activities of Pramipexole.]
[J04AC01, isoniazid, Pramipexole may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Pramipexole may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, Pramipexole may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Isoxsuprine.]
[N06AX18, reboxetine, Reboxetine may increase the sedative activities of Pramipexole.]
[S01AA24, kanamycin, Pramipexole may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Ketamine may increase the sedative activities of Pramipexole.]
[C02KD01, ketanserin, Ketanserin may increase the sedative activities of Pramipexole.]
[B01AC22, prasugrel, Pramipexole may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[H02CA04, levoketoconazole, The serum concentration of Pramipexole can be increased when it is combined with Levoketoconazole.]
[N05AH03, olanzapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N04BC09, rotigotine, Rotigotine may increase the sedative activities of Pramipexole.]
[D10AX03, azelaic acid, Pramipexole may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Labetalol.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02AA05, deserpidine, Pramipexole may increase the hypotensive activities of Deserpidine.]
[A06AX03, lubiprostone, Pramipexole may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, Lacosamide may increase the sedative activities of Pramipexole.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Pramipexole is combined with Levodopa.]
[S02DA01, lidocaine, Lidocaine may increase the sedative activities of Pramipexole.]
[S01AA21, amikacin, Pramipexole may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The serum concentration of Pramipexole can be increased when it is combined with Amiloride.]
[N02CA07, lisuride, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Lisuride.]
[N06AA07, lofepramine, Lofepramine may increase the sedative activities of Pramipexole.]
[N05BA06, lorazepam, Lorazepam may increase the sedative activities of Pramipexole.]
[N05AH01, loxapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Loxapine.]
[B05XA11, magnesium chloride, Pramipexole may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Pramipexole may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the sedative activities of Pramipexole.]
[L01BA05, pralatrexate, Pramipexole may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may increase the sedative activities of Pramipexole.]
[A08AA05, mazindol, Mazindol may increase the sedative activities of Pramipexole.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Mecamylamine.]
[R06AE05, meclizine, Meclizine may increase the sedative activities of Pramipexole.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05BA03, medazepam, Medazepam may increase the sedative activities of Pramipexole.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, Melatonin may increase the sedative activities of Pramipexole.]
[N06DX01, memantine, Pramipexole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may increase the sedative activities of Pramipexole.]
[N03AB04, mephenytoin, Mephenytoin may increase the sedative activities of Pramipexole.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the sedative activities of Pramipexole.]
[N01BB03, mepivacaine, Mepivacaine may increase the sedative activities of Pramipexole.]
[N05BC01, meprobamate, Meprobamate may increase the sedative activities of Pramipexole.]
[N02AX05, meptazinol, Meptazinol may increase the sedative activities of Pramipexole.]
[G04BX16, tiopronin, Pramipexole may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Mesoridazine.]
[N05AX13, paliperidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A04AA04, dolasetron, Dolasetron may increase the sedative activities of Pramipexole.]
[N07BC02, methadone, Methadone may increase the sedative activities of Pramipexole.]
[N06BA03, methamphetamine, Metamfetamine may increase the sedative activities of Pramipexole.]
[R06AC05, methapyrilene, Methapyrilene may increase the sedative activities of Pramipexole.]
[N05CM01, methaqualone, Methaqualone may increase the sedative activities of Pramipexole.]
[J05AF05, lamivudine, Pramipexole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AA30, metharbital, Metharbital may increase the sedative activities of Pramipexole.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may increase the sedative activities of Pramipexole.]
[H03BB02, methimazole, Pramipexole may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Pramipexole may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, Methocarbamol may increase the sedative activities of Pramipexole.]
[N05CA15, methohexital, Methohexital may increase the sedative activities of Pramipexole.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N02BG08, ziconotide, Ziconotide may increase the sedative activities of Pramipexole.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Methotrimeprazine.]
[D05BA02, methoxsalen, Pramipexole may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the sedative activities of Pramipexole.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Pramipexole is combined with Methyldopa.]
[V04CG05, methylene blue, Methylene blue may increase the sedative activities of Pramipexole.]
[G02AB01, methylergonovine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Methylergometrine.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Methylphenidate is combined with Pramipexole.]
[N03AF03, rufinamide, Rufinamide may increase the sedative activities of Pramipexole.]
[G03EK01, methyltestosterone, Pramipexole may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N05CE02, methyprylon, Methyprylon may increase the sedative activities of Pramipexole.]
[N02CA04, methysergide, Methysergide may increase the sedative activities of Pramipexole.]
[A03FA01, metoclopramide, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The serum concentration of Pramipexole can be increased when it is combined with Metoprolol.]
[V04CD01, metyrapone, Pramipexole may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Mianserin may increase the sedative activities of Pramipexole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may increase the sedative activities of Pramipexole.]
[J05AH01, zanamivir, Pramipexole may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Valsartan is combined with Pramipexole.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Pramipexole.]
[N05AE02, molindone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Molindone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pramipexole.]
[C01BD01, amiodarone, The serum concentration of Pramipexole can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may increase the sedative activities of Pramipexole.]
[N02AA01, morphine, Morphine may increase the sedative activities of Pramipexole.]
[A04AA05, palonosetron, Palonosetron may increase the sedative activities of Pramipexole.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Pramipexole may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Pramipexole may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Pramipexole may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, Vecuronium may increase the sedative activities of Pramipexole.]
[N05CA02, amobarbital, Amobarbital may increase the sedative activities of Pramipexole.]
[N06AA17, amoxapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Amoxapine.]
[N03AB05, fosphenytoin, Fosphenytoin may increase the sedative activities of Pramipexole.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nadolol.]
[J01CA04, amoxicillin, Pramipexole may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be decreased when Ropinirole is combined with Pramipexole.]
[C04AX21, nafronyl, Naftidrofuryl may increase the sedative activities of Pramipexole.]
[N02AF02, nalbuphine, Nalbuphine may increase the sedative activities of Pramipexole.]
[V03AB15, naloxone, Pramipexole may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Pramipexole is combined with Duloxetine.]
[N04BX01, tolcapone, Tolcapone may increase the sedative activities of Pramipexole.]
[S03AA01, neomycin, Pramipexole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, Remifentanil may increase the sedative activities of Pramipexole.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Pramipexole is combined with Levosimendan.]
[B01AC17, tirofiban, Pramipexole may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Pramipexole is combined with Amphotericin B.]
[S01AA19, ampicillin, Pramipexole may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Pramipexole may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Pramipexole may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the sedative activities of Pramipexole.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Pramipexole is combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C01CE01, inamrinone, Pramipexole may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the sedative activities of Pramipexole.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nicardipine.]
[N07BA01, nicotine, The serum concentration of Pramipexole can be increased when it is combined with Nicotine.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Pramipexole is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Nimodipine is combined with Pramipexole.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Nisoldipine is combined with Pramipexole.]
[N05CD02, nitrazepam, Nitrazepam may increase the sedative activities of Pramipexole.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, Pramipexole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may increase the sedative activities of Pramipexole.]
[N07XX04, sodium oxybate, Sodium oxybate may increase the sedative activities of Pramipexole.]
[C01DA05, pentaerythritol tetranitrate, Pramipexole may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Nitroprusside is combined with Pramipexole.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the sedative activities of Pramipexole.]
[N06AX04, nomifensine, Nomifensine may increase the sedative activities of Pramipexole.]
[C01CA03, norepinephrine, The serum concentration of Pramipexole can be increased when it is combined with Norepinephrine.]
[C02KX01, bosentan, Pramipexole may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the sedative activities of Pramipexole.]
[N06AA05, opipramol, Opipramol may increase the sedative activities of Pramipexole.]
[N02AA02, opium, Opium may increase the sedative activities of Pramipexole.]
[G02CB04, quinagolide, The risk or severity of adverse effects can be decreased when Pramipexole is combined with Quinagolide.]
[G04CA02, tamsulosin, The risk or severity of adverse effects can be increased when Pramipexole is combined with Tamsulosin.]
[J01CF04, oxacillin, Pramipexole may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may increase the sedative activities of Pramipexole.]
[C07AA02, oxprenolol, Oxprenolol may increase the sedative activities of Pramipexole.]
[N02AA05, oxycodone, Oxycodone may increase the sedative activities of Pramipexole.]
[N02AA11, oxymorphone, Oxymorphone may increase the sedative activities of Pramipexole.]
[N05AE01, oxypertine, Oxypertine may increase the sedative activities of Pramipexole.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Pramipexole can be increased when it is combined with Aminohippuric acid.]
[N05AH05, asenapine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the sedative activities of Pramipexole.]
[M03AC01, pancuronium, Pancuronium may increase the sedative activities of Pramipexole.]
[J04AB30, capreomycin, Pramipexole may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Papaverine.]
[N05CC05, paraldehyde, Paraldehyde may increase the sedative activities of Pramipexole.]
[C02KC01, pargyline, Pargyline may increase the sedative activities of Pramipexole.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G04BD11, fesoterodine, Pramipexole may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may increase the sedative activities of Pramipexole.]
[N05AG03, penfluridol, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Penfluridol.]
[J01CE09, penicillin G procaine, Pramipexole may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N02AD01, pentazocine, Pentazocine may increase the sedative activities of Pramipexole.]
[N05CA01, pentobarbital, Pentobarbital may increase the sedative activities of Pramipexole.]
[L01XX08, pentostatin, Pramipexole may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pramipexole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05AB10, perazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Perazine.]
[N04BC02, pergolide, Pergolide may increase the sedative activities of Pramipexole.]
[N05AB03, perphenazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Perphenazine.]
[N02AD02, phenazocine, Phenazocine may increase the sedative activities of Pramipexole.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the sedative activities of Pramipexole.]
[A10BA01, phenformin, The serum concentration of Pramipexole can be increased when it is combined with Phenformin.]
[N03AA02, phenobarbital, Phenobarbital may increase the sedative activities of Pramipexole.]
[N01AH04, phenoperidine, Phenoperidine may increase the sedative activities of Pramipexole.]
[C04AX02, phenoxybenzamine, The serum concentration of Pramipexole can be increased when it is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Pramipexole is combined with Phentolamine.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[N03AB02, phenytoin, Phenytoin may increase the sedative activities of Pramipexole.]
[S01AE05, levofloxacin, Pramipexole may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Pramipexole may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C08CX01, mibefradil, Pramipexole may increase the hypotensive activities of Mibefradil.]
[N05AG02, pimozide, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Pimozide.]
[C07AA03, pindolol, Pindolol may increase the sedative activities of Pramipexole.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J05AE01, saquinavir, The risk or severity of adverse effects can be increased when Saquinavir is combined with Pramipexole.]
[N05AC04, pipothiazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Pipotiazine.]
[N06BX03, piracetam, Pramipexole may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Pramipexole is combined with Eprosartan.]
[N04BC08, piribedil, The risk or severity of adverse effects can be decreased when Pramipexole is combined with Piribedil.]
[N02AC03, pirinitramide, Piritramide may increase the sedative activities of Pramipexole.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[J01MA11, grepafloxacin, The serum concentration of Pramipexole can be increased when it is combined with Grepafloxacin.]
[N02CX01, pizotyline, Pizotifen may increase the sedative activities of Pramipexole.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Pramipexole is combined with Irbesartan.]
[N05CA22, proxibarbal, Proxibarbal may increase the sedative activities of Pramipexole.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A03AE01, alosetron, Alosetron may increase the sedative activities of Pramipexole.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH03, saxagliptin, Pramipexole may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Pramipexole may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C07AB01, practolol, Pramipexole may increase the hypotensive activities of Practolol.]
[N05BA11, prazepam, Prazepam may increase the sedative activities of Pramipexole.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Pramipexole.]
[H02AB07, prednisone, Pramipexole may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, Prilocaine may increase the sedative activities of Pramipexole.]
[N03AA03, primidone, Primidone may increase the sedative activities of Pramipexole.]
[M04AB01, probenecid, The serum concentration of Pramipexole can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Pramipexole may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, Procaine may increase the sedative activities of Pramipexole.]
[L01XB01, procarbazine, Procarbazine may increase the sedative activities of Pramipexole.]
[C10AB05, fenofibrate, Pramipexole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AB04, prochlorperazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Prochlorperazine.]
[G03DA04, progesterone, The serum concentration of Pramipexole can be increased when it is combined with Progesterone.]
[N05AA03, promazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Promethazine.]
[N01AX04, propanidid, Propanidid may increase the sedative activities of Pramipexole.]
[A03AB05, propantheline, Pramipexole may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N05AC01, periciazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Periciazine.]
[N05CM06, propiomazine, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Propiomazine.]
[N01AX10, propofol, Propofol may increase the sedative activities of Pramipexole.]
[N02AC04, propoxyphene, Dextropropoxyphene may increase the sedative activities of Pramipexole.]
[C07AA05, propranolol, The serum concentration of Pramipexole can be increased when it is combined with Propranolol.]
[N02CC04, rizatriptan, Rizatriptan may increase the sedative activities of Pramipexole.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Epoprostenol.]
[N06AA11, protriptyline, Protriptyline may increase the sedative activities of Pramipexole.]
[N05AX12, aripiprazole, The therapeutic efficacy of Pramipexole can be decreased when used in combination with Aripiprazole.]
[N07XX07, dalfampridine, Pramipexole may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[N05CA07, talbutal, Talbutal may increase the sedative activities of Pramipexole.]
[N05CA09, vinbarbital, Vinbarbital may increase the sedative activities of Pramipexole.]
[N05BB02, captodiamine, Captodiame may increase the sedative activities of Pramipexole.]
[M03BA04, styramate, Styramate may increase the sedative activities of Pramipexole.]
[P02CC01, pyrantel, Pyrantel may increase the sedative activities of Pramipexole.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[R06AC01, pyrilamine, Mepyramine may increase the sedative activities of Pramipexole.]
[P01AX05, quinacrine, The serum concentration of Pramipexole can be increased when it is combined with Quinacrine.]
[C01BA01, quinidine, Pramipexole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, Quinine may increase the sedative activities of Pramipexole.]
[A02BA02, ranitidine, The serum concentration of Pramipexole can be increased when it is combined with Ranitidine.]
[C02AA01, rescinnamine, Pramipexole may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, Reserpine may increase the sedative activities of Pramipexole.]
[J05AP01, ribavirin, Pramipexole may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the sedative activities of Pramipexole.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[S01FA02, scopolamine, Scopolamine may increase the sedative activities of Pramipexole.]
[N05CA06, secobarbital, Secobarbital may increase the sedative activities of Pramipexole.]
[N04BD01, selegiline, Selegiline may increase the sedative activities of Pramipexole.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Pramipexole is combined with Obinutuzumab.]
[J01GB08, sisomicin, Pramipexole may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Pramipexole may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Pramipexole may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Pramipexole is combined with Sotalol.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.]
